Perfil
Michael Williams is currently a Board Member at Sarcio, Inc. and a Partner at PACE Healthcare Capital.
Previously, he served as a Non-Executive Director at PYC Therapeutics Ltd. in 2018 and as a Vice President at Bristol Myers Squibb Co. from 2004 to 2005.
He also held positions at Pfizer Inc. as a Vice President and at Intarcia Therapeutics, Inc. as a Chief Operating Officer.
Mr. Williams obtained his undergraduate degree from the University Of Bangor and his graduate degree in 1982 from the same institution.
Cargos activos de Michael Williams
| Empresas | Cargo | Inicio |
|---|---|---|
PACE Healthcare Capital
PACE Healthcare Capital Investment ManagersFinance PACE Healthcare invests in companies located in the United States. The firm focuses on digital healthcare and healthcare technology sectors. It provides financing for seed and early-stage capital requirements with an investment size of USD 0.25 - 2 million. | Consultor / Asesor | - |
Sarcio, Inc.
Sarcio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in developing an off the shelf, injectable, regenerative therapy to delay or prevent the need for joint replacement | Director/Miembro de la Junta | 01/07/2021 |
Antiguos cargos conocidos de Michael Williams.
| Empresas | Cargo | Fin |
|---|---|---|
| PYC THERAPEUTICS LIMITED | Director/Miembro de la Junta | 11/04/2018 |
| BRISTOL-MYERS SQUIBB COMPANY | Inversor de Capital Privado | 01/01/2005 |
| PFIZER INC. | Inversor de Capital Privado | - |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Director de Operaciones | - |
Formación de Michael Williams.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 7 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
PYC Therapeutics Ltd.
PYC Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides discovery and development of peptide based therapeutic candidates | Health Technology |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Health Technology |
University Of Bangor
University Of Bangor Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sarcio, Inc.
Sarcio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in developing an off the shelf, injectable, regenerative therapy to delay or prevent the need for joint replacement | Commercial Services |
PACE Healthcare Capital
PACE Healthcare Capital Investment ManagersFinance PACE Healthcare invests in companies located in the United States. The firm focuses on digital healthcare and healthcare technology sectors. It provides financing for seed and early-stage capital requirements with an investment size of USD 0.25 - 2 million. | Finance |
- Bolsa de valores
- Insiders
- Michael Williams
















